23andMe associated_with ADHD
Evidence from:
primary |
all sources
Evidence (5 sources)
Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder.
(2019)
PMID:30478444
cited
Genetic correlation with 23andMe was weaker but still strongly positive (rg = 0.653, SE = 0.114, P = 1.11 × 10−8).
confidence: 0.95
Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder.
(2019)
PMID:30478444
cited
Specifically, for each of deCODE and 23andMe we regressed the effect size in the replication cohort ... on the estimated effect size from the ADHD GWAS
confidence: 0.92
Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder.
(2019)
PMID:30478444
cited
replication analyses (i.e. deCODE, 23andMe, and EAGLE/QIMR) were used to test concordance with the ADHD GWAS
confidence: 0.93
Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder.
(2019)
PMID:30478444
cited
genetic correlation of the 23andMe cohort with the ADHD GWAS
confidence: 0.85
Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder.
(2019)
PMID:30478444
cited
analysis of self-reported ADHD status in 23andMe
confidence: 0.85